参考文献/References:
[1] 胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志 ,2019,34(3):209-220.
[2] Tang WHW,Li DY,Hazen SL. Dietary metabolism,the gut microbiome,and heart failure[J]. Nat Rev Cardiol,2019,16(3):137-154.
[3] Pluznick JL. Microbial short-chain fatty acids and blood pressure regulation[J]. Curr Hypertens Rep,2017,19(4):25.
[4] Tazoe H,Otomo Y,Kaji I,et al. Roles of short-chain fatty acids receptors,GPR41 and GPR43 on colonic functions[J]. J Physiol Pharmacol,2008,59 Suppl 2:251-262.
[5] Hu J,Lin S,Zheng B,et al. Short-chain fatty acids in control of energy metabolism[J]. Crit Rev Food Sci Nutr,2018,58(8):1243-1249.
[6] Bolognini D,Tobin AB,Milligan G,et al. The pharmacology and function of receptors for short-chain fatty acids[J]. Mol Pharmacol,2016,89(3):388-398.
[7] Yang T,Santisteban MM,Rodriguez V,et al. Gut dysbiosis is linked to hypertension[J]. Hypertension,2015,65(6):1331-1340.
[8] Li J,Zhao F,Wang Y,et al. Gut microbiota dysbiosis contributes to the development of hypertension[J]. Microbiome,2017,5(1):14.
[9] Qi Y,Aranda JM,Rodriguez V,et al. Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension—A case report[J]. Int J Cardiol,2015,201:157-158.
[10] Pluznick JL. Renal and cardiovascular sensory receptors and blood pressure regulation[J]. Am J Physiol Renal Physiol,2013,305(4):F439-F444.
[11] Marques FZ,Nelson E,Chu PY,et al. High-fiber fiet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice[J]. Circulation,2017,135(10):964-977.
[12] Pluznick JL,Protzko RJ,Gevorgyan H,et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation[J]. Proc Natl Acad Sci U S A,2013,110(11):4410-4415.
[13] Wu MY,Li CJ. New insights into the role of inflammation in the pathogenesis of atherosclerosis[J]. Int J Mol Sci, 2017,18(10),pii: E2034.
[14] Jonsson AL,Backhed F. Role of gut microbiota in atherosclerosis[J]. Nat Rev Cardiol,2017,14(2):79-87.
[15] Li DY,Tang W. Gut microbiota and atherosclerosis[J]. Curr Atheroscler Rep,2017,19(10):39.
[16] Kasahara K,Krautkramer KA,Org E,et al. Interactions between roseburia intestinalis and diet modulate atherogenesis in a murine model[J]. Nat Microbiol,2018,3(12):1461-1471.
[17] Kitai T,Tang WHW. Gut microbiota in cardiovascular disease and heart failure[J]. Clin Sci (Lond),2018,132(1):85-91.
[18] Nagatomo Y,Tang WH. Intersections between microbiome and heart failure:revisiting the gut hypothesis[J]. J Card Fail,2015,21(12):973-980.
[19] Jakobsson HE,Rodriguez-Pineiro AM,Schutte A,et al. The composition of the gut microbiota shapes the colon mucus barrier[J]. EMBO Rep,2015,16(2):164-177.
[20] Hur KY,Lee MS. Gut microbiota and metabolic disorders[J]. Diabetes Metab J,2015,39(3):198-203.
[21] Ortega FB,Lavie CJ,Blair SN. Obesity and cardiovascular disease[J]. Circ Res,2016,118(11):1752-1770.
[22] Kachur S,Lavie CJ,de Schutter A,et al. Obesity and cardiovascular diseases[J]. Minerva Med,2017,108(3):212-228.
[23] Schwiertz A,Taras D,Schafer K,et al. Microbiota and SCFA in lean and overweight healthy subjects[J]. Obesity (Silver Spring),2010,18(1):190-195.
[24] Chambers ES,Viardot A,Psichas A,et al. Effects of targeted delivery of propionate to the human colon on appetite regulation ,body weight maintenance and adiposity in overweight adults[J]. Gut,2015,64(11):1744-1754.
[25] Tan J,McKenzie C,Potamitis M,et al. The role of short-chain fatty acids in health and disease[J]. Adv Immunol,2014,121:91-119.
[26] Pirlich M,Schutz T,Kemps M,et al. Prevalence of malnutrition in hospitalized medical patients:impact of underlying disease[J]. Dig Dis,2003,21(3):245-251.
[27] Venter CS,Vorster HH,Cummings JH. Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers[J]. Am J Gastroenterol,1990,85(5):549-553.
[28] Reynolds A,Mann J,Cummings J,et al. Carbohydrate quality and human health:a series of systematic reviews and meta-analyses[J]. Lancet,2019,393(10170):434-445.
[29] LeBlanc JG,Chain F,Martin R,et al. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria[J]. Microb Cell Fact,2017,16(1):79.
[30] Smits LP,Bouter KE,de Vos WM,et al. Therapeutic potential of fecal microbiota transplantation[J]. Gastroenterology,2013,145(5):946-953.
[31] Seekatz AM,Theriot CM,Rao K,et al. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection[J]. Anaerobe,2018,53:64-73.
[32] Pouteau E,Nguyen P,Ballevre O,et al. Production rates and metabolism of short-chain fatty acids in the colon and whole body using stable isotopes[J]. Proc Nutr Soc,2003,62(1):87-93.